Nigeria to Receive Additional 42 Million Doses of Covid-19 Vaccines

Spread the news

Initial doses of AstraZeneca COVID-19 vaccines through the COVAX Global Assessment Facility are scheduled to be given to Nigeria at 16 million doses. 

Nigeria Minister for Health Osagie Ehanire, said Monday that, in addition to the initially planned 16 million doses, it would receive 42 million additional doses of approved COVID-19 vaccines. The initial doses of AstraZeneca COVID-19 vaccines in Nigeria were estimated to be 16 millions by the end of February through the Vaccines Global Assessment Facility (COVAX). 

Mr Ehanire, speaking in the COVID-19 briefing at the Presidential Task Force, reported that the African Union Procurement team of African Vaccines would deliver the country with 42 million doses (AVATT). Nigeria has subscribed to two multilateral networks for vaccine access, first of all the COvax facility set up in 92 Low- and Middle-Income countries to divide over one billion doses of vaccine.

Data source: Premium Times

TOA Correspondent

Recent Posts

The top Nigerian who hated his own voice

Nigeria’s leading music figure and vocalist, Cobhams Asuquo, known for his singing and production said…

3 years ago

South African court halts Amazon HQ project

Following a mixed reaction from the South African community representatives, Khoi and San, the Cape…

3 years ago

How Digitalization in African Rail Transportation Is Enhancing Safety?

Mitigating the process and service barriers in African rail transportation, the digital disruption has transformed…

3 years ago

Tunisian leader to allow public views on reforms

Kais Saied, the Tunisian president has said in his speech that he will allow the…

3 years ago

The power of Niacinamide in the trending African skincare market

You know the credibility of an ingredient when it’s plastered all over bottles and jars…

3 years ago

Mozambique death toll from Cyclone Gombe rises to 48

Cyclone Gombe that flooded large areas of central and northern Mozambique is consistently leading to…

3 years ago

This website uses cookies.